Pipeline Update: Didi Chuxing among parade of new IPO filings

NEW FILINGS

Company: NYXOAH SA
Symbol: NYXH (Nasdaq)
Description: They are a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea, or OSA.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriters: Piper Sandler, Stifel, Cantor
Co Manager: Degroof Petercam
Link to Prospectus: Filed: 6-10-21

Company: Xiaoju Kuaizhi Inc.
Symbol: DIDI (NYSE)
Description: They are the world’s largest mobility technology platform. They are the go-to brand in China for shared mobility, providing consumers with a comprehensive range of safe, affordable and convenient mobility services, including ride hailing, taxi hailing, chauffeur, hitch and other forms of shared mobility.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriters: Goldman Sachs, Morgan Stanley, JP Morgan
Co Manager: China Renaissance
Link to Prospectus: Filed: 6-10-21
Listed Cash Raise: $100m

Company: Ocean Biomedical Inc.
Symbol: OCEA (Nasdaq)
Description: They are a biopharmaceutical company that seeks to bridge the “bench-to-bedside” gap between medical research discoveries and patient solutions.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriters: Berenberg, Oppenheimer & Co.
Co Manger: LifeSci Capital, Ladenburg Thalmann, Brookline Capital Markets, Roth Capital
Link to Prospectus: Filed: 6-9-21
Listed Cash Raise: $100m

Company: Aerovate Therapeutics Inc.
Symbol: AVTE (Nasdaq)
Description: They are a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriters: Jefferies, Cowen, Evercore
Co Manger: Wedbush PacGrow
Link to Prospectus: Filed: 6-9-21
Listed Cash Raise: $100m

Company: Acumen Pharmaceuticals Inc.
Symbol: ABOS (Nasdaq)
Description: They are a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what we believe to be a key underlying cause of Alzheimer’s disease, or AD.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriters: BofA Securities, Credit Suisse, Stifel
Co Manger: UBS Investment Bank
Link to Prospectus: Filed: 6-9-21
Listed Cash Raise: $100m

Company: Dingdong (Cayman) Limited
Symbol: DDL (NYSE)
Description: They are a leading and the fastest growing on-demand e-commerce company in China, according to China Insights Consultancy, or CIC.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriters: Morgan Stanley, BofA Securities, Credit Suisse
Link to Prospectus: Filed: 6-8-21
Listed Cash Raise: $100m

Company: Missfresh Limited
Symbol: MF
Description: Missfresh is rebuilding neighborhood retail from the ground up in China with our innovative technology and business model.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriters: JP Morgan, Citigroup, CICC, China Renaissance
Co-Manager(s): CMBI, ICBC International, Needham & Co., FUTU, Tiger Brokers
Link to Prospectus: Filed: 6-8-21
Listed Cash Raise: $100m

Company: Atour Lifestyle Holdings Limited
Symbol: ATAT
Description: They are the largest upper midscale hotel chain in China in terms of room number as of the end of 2020, according to Frost & Sullivan.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriters: BofA Securities, Citigroup
Co-Manager(s): CICC, CMBI
Link to Prospectus: Filed: 6-8-21
Listed Cash Raise: $100m

Company: Torrid Holdings, Inc.
Symbol: CURV (NYSE)
Description: Torrid is the largest direct-to-consumer brand of women’s plus-size apparel and intimates in North America by net sales.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriters: Morgan Stanley, BofA Securities, Goldman Sachs, Jefferies
Co-Manager(s): Baird, Cowen, William Blair, Telsey Advisory Group
Link to Prospectus: Filed: 6-7-21
Listed Cash Raise: $100m
Company Originally Filed in July 2017

Company: Clear Secure, Inc.
Symbol: YOU (NYSE)
Description: They have built an extensive physical footprint with a nationwide network of airports, stadiums and businesses to offer members frictionless, trusted experiences as they move and transact throughout the day in both physical and digital environments.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriters: Goldman Sachs, JP Morgan, Allen & Co., Wells Fargo
Co-Manager(s): LionTree, Stifel, Telsey Advisory Group, Centerview Partners, Loop Capital, Roberts & Ryan
Link to Prospectus: Filed: 6-7-21
Listed Cash Raise: $100m

Company: LegalZoom.com Inc.
Symbol: LZ
Description: LegalZoom is a leading online platform for legal and compliance solutions in the United States. In 2020, 10% of new limited liability companies, or LLCs, and 5% of new corporations in the United States were formed via LegalZoom.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriters: JP Morgan, Morgan Stanley, Barclays, BofA Securities, Citigroup, Credit Suisse, Jefferies
Co-Manager(s): JMP Securities, Raymond James, William Blair
Link to Prospectus: Filed: 6-4-21
Listed Cash Raise: $100m

Company: CVRx, Inc.
Symbol: CVRX
Description: They are a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative and minimally invasive neuromodulation solutions for patients with cardiovascular diseases.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriters: JP Morgan, Piper Sandler, William Blair
Co-Manager(s): Canaccord Genuity
Link to Prospectus: Filed: 6-4-21
Listed Cash Raise: $75m

Company: Graphite Bio, Inc.
Symbol: GRPH
Description: They are a clinical-stage, next-generation gene editing company harnessing high efficiency targeted gene integration to develop a new class of therapies to potentially cure a wide range of serious and life-threatening diseases.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriters: Morgan Stanley, BofA Securities, Cowen, SVB Leerink
Link to Prospectus: Filed: 6-4-21
Listed Cash Raise: $100m

Company: Intapp, Inc.
Symbol: INTA
Description: Intapp is a leading provider of industry-specific, cloud-based software solutions for the professional and financial services industry globally.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriters: JP Morgan, BofA Securities, Credit Suisse
Co-Manager(s): Piper Sandler, Raymond James, Oppenheimer, Stifel, Truist Securities
Link to Prospectus: Filed: 6-4-21
Listed Cash Raise: $100m

Company: GH Research PLC
Symbol: GHRS
Description: They are a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriters: Cowen, Stifel
Co-Manager(s): Canaccord Genuity, JMP Securities
Link to Prospectus: Filed: 6-4-21
Listed Cash Raise: $100m

Company: Alpha Teknova, Inc.
Symbol: TKNO
Description: They are a leading provider of critical reagents that enable the discovery, research, development and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriters: Cowen, William Blair
Co-Manager(s): BTIG, Stephens
Link to Prospectus: Filed: 6-4-21
Listed Cash Raise: $75m

Company: Elevation Oncology, Inc.
Symbol: ELEV
Description: They are a precision oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriters: JP Morgan, Cowen, SVB Leerink
Co-Manager(s): Wedbush PacGrow
Link to Prospectus: Filed: 6-4-21
Listed Cash Raise: $100m

Company: Monte Rosa Therapeutics, Inc.
Symbol: GLUE
Description: They are a biopharmaceutical company developing a portfolio of novel small molecule precision medicines that employ the body’s natural mechanisms to selectively degrade therapeutically-relevant proteins.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriters: JP Morgan, Cowen, Piper Sandler, Guggenheim
Link to Prospectus: Filed: 6-4-21
Listed Cash Raise: $100m

UPDATED TERMS

Company: Lyell Immunopharma, Inc.
Symbol: LYEL
Description: They are a T cell reprogramming company dedicated to the mastery of T cells to cure patients with solid tumors.
Shares: 25 million
Price Range: $16.00-$18.00
Market Cap: $3.9b-$4.4b
Trade Date: Thursday, 6/17
Underwriter(s): Goldman Sachs, BofA Securities, JP Morgan, Morgan Stanley
Link to Prospectus: Terms Added: 6-9-21

Company: Molecular Partners Inc.
Symbol: MOLN
Description: They are a clinical stage biopharmaceutical company applying our pioneering DARPin® product candidates to treat serious diseases, with a current focus on infectious disease, oncology and ophthalmology.
Shares: 3 million ADSs
Price Range: $27.14-$27.14
Market Cap: $873m-$873m
Trade Date: Wednesday, 6/16
Underwriter(s): JP Morgan, SVB Leerink, Cowen, RBC Capital
Co-Manager: Kempen & Co.
Link to Prospectus: Terms Added: 6-9-21
Listed Cash Raise: $100m
Note: Their common shares are listed on the SIX Swiss Exchange Ltd, or the SIX Swiss Exchange, under the symbol “MOLN”.

Company: Unicycive Therapeutics Inc.
Symbol: UNCY
Description: They are a biotechnology company dedicated to developing treatments for certain medical conditions.
Shares: 2.6 million
Price Range: $8.50-$10.50
Market Cap: $100m-$124m
Trade Date: Friday, 6/18
Underwriter(s): Roth Capital
Co Managers: Kingswood Capital
Link to Prospectus: Terms Added: 6-7-21

Company: WalkMe Ltd.
Symbol: WKME
Description: They are the defining solution enabling organizations to better realize the value of their software investments.
Shares: 9.25 million
Price Range: $29.00-$32.00
Market Cap: $2.4b-$2.65b
Trade Date: Wednesday 6/16
Underwriter(s): Morgan Stanley, Goldman Sachs, Citigroup
Co Managers: Wells Fargo, Barclays, BMO Capital, JMP Securities, KeyBanc Capital Markets, Needham & Company
Link to Prospectus: Terms Added: 6-7-21

Company: AMTD Digital, Inc.
Symbol: HKD
Description: They are one of the most comprehensive digital solutions platforms in Asia with businesses spanning multiple verticals, including digital financial services, SpiderNet ecosystem solutions, digital media, content, and marketing, and digital investments.
Shares: 16 million ADSs
Price Range: $6.80-$8.20
Market Cap: $1.3b-$1.5b
Trade Date: Tuesday, 6/15
Underwriter(s): AMTD
Co Managers: Loop Capital, Maxim Group, Livermore Holdings
Link to Prospectus: Terms Added: 6-7-21

Company: Angel Oak Mortgage, Inc.
Symbol: AOMR
Description: Angel Oak Mortgage, Inc. is a real estate finance company focused on acquiring and investing in first lien non-QM loans and other mortgage-related assets in the U.S. mortgage market.
Shares: 8.05 million
Price Range: $20.00-$21.00
Market Cap: $524m-$551m
Trade Date: Thursday, 6/17
Underwriter(s): Wells Fargo, BofA Securities, Morgan Stanley, UBS Investment Bank, B.Riley Securities
Co Managers: Nomura, Oppenheimer & Co.
Link to Prospectus: Terms Added: 6-8-21

Company: Convey Holding Parent, Inc.
Symbol: CNVY (NYSE)
Description: Convey Health is a leading healthcare platform that utilizes technology and processes to improve government-sponsored health plans, including Medicare Advantage (“MA”).
Shares: 13.3 million
Price Range: $14.00-$16.00
Market Cap: $1.0b-$1.2b
Trade Date: Wednesday, 6/16
Underwriter(s): BofA Securities, Goldman Sachs, JP Morgan, Barclays
Co Managers: TPG Capital BD LLC, Truist Securities, Canaccord Genuity
Link to Prospectus: Terms Added: 6-7-21